Online Editor Robert Steinbrook News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels was $1.5 billion.

United statesAlexanderc egilmanRobert steinbrookDrug administrationHarvard medical schoolMedicine editorial fellow eric wardMedicine editorOnline editor robert steinbrookFederal circuitFirst amendmentBiologic therapyBiosimilar drugsFollow on biologicsGeneric drugEneric medicationAngiogenesis inhibitor